In this issue:
Atezolizumab in early-stage triple-negative breast cancer
Adjuvant chemotherapy in older women with high-risk breast cancer
Prevention of sacituzumab govitecan-related neutropenia and diarrhoea
Breast cancer mortality with antidepressants, anxiolytics, and antipsychotics
HER2DX in early-stage HER2-positive breast cancer
Post-trastuzumab deruxtecan treatment in HER2-positive metastatic breast cancer
Concordance of local versus central Ki67 measurements
Trastuzumab deruxtecan in HER2-expressing metastatic breast cancer
Breastfeeding after hormone receptor-positive breast cancer
Clinical practice guidelines for long-term breast cancer survivorship
Please login below to download this issue (PDF)